BRIEF published on 08/06/2024 at 22:10, 2 years ago Nyxoah Reports Financial Results for Q2 and H1 2024 Revenue Growth Capital Raise Operational Highlights FDA Submission Q2 2024 Results
PRESS RELEASE published on 08/06/2024 at 22:05, 2 years ago Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results Nyxoah SA reports financial and operating results for the second quarter and first half of 2024, including FDA submission completion and U.S. approval progress Financial Results Operating Results FDA Submission Nyxoah SA U.S. Approval
BRIEF published on 07/15/2024 at 08:20, 2 years 1 month ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer FDA Approval Medical Device Industry Nyxoah Obstructive Sleep Apnea Scott Holstine
PRESS RELEASE published on 07/15/2024 at 08:15, 2 years 1 month ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/03/2024 at 12:35, 2 years 1 month ago Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
PRESS RELEASE published on 07/03/2024 at 12:30, 2 years 1 month ago Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Nyxoah signs a €37.5 million loan facility agreement with the European Investment Bank to boost research, development, and manufacturing capacity for sleep apnea solutions Research And Development European Investment Bank Sleep Apnea Nyxoah €37.5 Million Loan
Published on 08/31/2026 at 02:05, 8 hours 26 minutes ago Tunkillia Infill Drilling Confirms New High-grade Mineralisation Within Shallow Zone of Existing High-value 'Starter Pit' Outlines
Published on 08/29/2026 at 05:15, 2 days 5 hours ago Norsemont Announces Restatement of Financial Statements
Published on 08/29/2026 at 03:20, 2 days 7 hours ago BEACN Announces Financial Results for the Second Quarter of 2026
Published on 08/29/2026 at 01:15, 2 days 9 hours ago Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500
Published on 08/31/2026 at 10:01, 30 minutes ago Sto SE & Co. KGaA Group turnover rises by 3.7 % to EUR 805.5 million by the end of June 2026
Published on 08/31/2026 at 10:00, 31 minutes ago BOOSTER Precision Components Holding GmbH publishes H1 2026 results
Published on 08/31/2026 at 09:30, 1 hour 1 minute ago HÖRMANN Industries publishes interim report for the first half of 2026
Published on 08/31/2026 at 09:12, 1 hour 19 minutes ago Leasing success in Baar: new office building fully leased before construction start
Published on 08/31/2026 at 07:00, 3 hours 31 minutes ago Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Published on 08/26/2026 at 18:02, 4 days 16 hours ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 4 days 16 hours ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
